Filed: 5/15/2024ACC: 0001012975-24-000230
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $80.28M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$80.28M
Total AUM (reported)
28.07M
Total Shares
Allocation by class
COM$75.84M94.5%
CLASS A COM$4.43M5.5%
Portfolio Concentration
Top 3$58.96M73.4%
4–10$21.32M26.6%
Top 3 weight
73.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 28.07M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
28.07M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings8
Rows:
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$26.68M
33.23%
Sole
0.00
Shared
0.00
None
2.01M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$22.77M
28.37%
Sole
0.00
Shared
0.00
None
11.06M
GOSSAMER BIO, INC.
SOLEShares8.06M
TypeSH
Market value$9.51M
11.84%
Sole
0.00
Shared
0.00
None
8.06M
DENALI THERAPEUTICS, INC.
SOLEShares381.25K
TypeSH
Market value$7.82M
9.75%
Sole
0.00
Shared
0.00
None
381.25K
Q32 BIO INC.
SOLEShares320.48K
TypeSH
Market value$5.46M
6.80%
Sole
0.00
Shared
0.00
None
320.48K
CERO THERAPEUTICS HOLDINGS, INC.
SOLEShares1.44M
TypeSH
Market value$4.43M
5.52%
Sole
0.00
Shared
0.00
None
1.44M
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares3.80M
TypeSH
Market value$1.95M
2.43%
Sole
0.00
Shared
0.00
None
3.80M
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$1.65M
2.05%
Sole
0.00
Shared
0.00
None
1M
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $26.68M 33.23% | 0.00 | 0.00 | 2.01M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $22.77M 28.37% | 0.00 | 0.00 | 11.06M |
GOSSAMER BIO, INC.SOLE | COM | 8.06M | SH | $9.51M 11.84% | 0.00 | 0.00 | 8.06M |
DENALI THERAPEUTICS, INC.SOLE | COM | 381.25K | SH | $7.82M 9.75% | 0.00 | 0.00 | 381.25K |
Q32 BIO INC.SOLE | COM | 320.48K | SH | $5.46M 6.80% | 0.00 | 0.00 | 320.48K |
CERO THERAPEUTICS HOLDINGS, INC.SOLE | CLASS A COM | 1.44M | SH | $4.43M 5.52% | 0.00 | 0.00 | 1.44M |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM | 3.80M | SH | $1.95M 2.43% | 0.00 | 0.00 | 3.80M |
UNITY BIOTECHNOLOGY, INC.SOLE | COM | 1M | SH | $1.65M 2.05% | 0.00 | 0.00 | 1M |